Featured Publications
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Cluett J, Blazek O, Brown A, East C, Ferdinand K, Fisher N, Ford C, Griffin K, Mena-Hurtado C, Sarathy H, Vongpatanasin W, Townsend R, Disease O. Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension 2024, 81: e135-e148. PMID: 39101202, DOI: 10.1161/hyp.0000000000000240.Peer-Reviewed Original ResearchRenal denervationBlood pressureEfficacy of renal denervationUS Food and Drug AdministrationRandomized clinical studyRenal sympathetic nervesNovel treatment strategiesBlood pressure control ratesLonger-term efficacyIndividual patient responseLowering blood pressureFood and Drug AdministrationSpectrum of hypertensionTreatment of hypertensionControl blood pressureUncontrolled blood pressureMultiple ongoing studiesCatheter-based proceduresAmerican Heart AssociationHigh blood pressureTherapeutic optionsSafety profileCardiovascular morbidityControl rateHypertension specialists
2014
Renal sympathetic denervation in the treatment of resistant hypertension.
Sánchez-Álvarez C, González-Vélez M, Stilp E, Ward C, Mena-Hurtado C. Renal sympathetic denervation in the treatment of resistant hypertension. The Yale Journal Of Biology And Medicine 2014, 87: 527-35. PMID: 25506285, PMCID: PMC4257026.Peer-Reviewed Original ResearchConceptsTreatment-resistant hypertensionRenal sympathetic denervationSympathetic denervationBlood pressureRenal arteryEfficacy of RSDSYMPLICITY HTN-3 studyDifferent antihypertensive medicationsSympathetic nerve hyperactivityMinor adverse eventsTarget blood pressureCommon femoral arteryMain renal arteryMajor health problemAntihypertensive medicationsRenal denervationRenal sympathectomySymplicity catheterArterial hypertensionResistant hypertensionAdverse eventsConsiderable morbidityEndovascular approachFemoral arteryConcomitant use